STRATA Skin Sciences Faces Delisting Notice
Ticker: SSKN · Form: 8-K · Filed: Jun 25, 2024 · CIK: 1051514
| Field | Detail |
|---|---|
| Company | Strata Skin Sciences, Inc. (SSKN) |
| Form Type | 8-K |
| Filed Date | Jun 25, 2024 |
| Risk Level | high |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-standards, regulatory
TL;DR
STRATA Skin Sciences got a notice about failing to meet listing rules - could be delisted.
AI Summary
STRATA Skin Sciences, Inc. filed an 8-K on June 25, 2024, to report a notice of delisting or failure to satisfy a continued listing rule or standard. The company was formerly known as MELA SCIENCES, INC. and ELECTRO OPTICAL SCIENCES INC.
Why It Matters
This filing indicates potential issues with STRATA Skin Sciences' continued listing on an exchange, which could impact its stock trading and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's continued operation and stock viability.
Key Players & Entities
- STRATA Skin Sciences, Inc. (company) — Registrant
- MELA SCIENCES, INC. (company) — Former Company Name
- ELECTRO OPTICAL SCIENCES INC (company) — Former Company Name
- June 24, 2024 (date) — Date of Earliest Event Reported
- June 25, 2024 (date) — Date of Report
FAQ
What specific listing rule or standard has STRATA Skin Sciences failed to satisfy?
The filing does not specify the exact rule or standard that STRATA Skin Sciences has failed to satisfy, only that a notice has been received.
What is the potential consequence of failing to satisfy a continued listing rule?
Failure to satisfy a continued listing rule or standard can lead to the transfer of a company's listing to a different exchange or, in severe cases, delisting.
When was STRATA Skin Sciences previously known by other names?
The company was formerly known as MELA SCIENCES, INC. since May 4, 2010, and prior to that, as ELECTRO OPTICAL SCIENCES INC since December 16, 1997.
What is the principal executive office address for STRATA Skin Sciences, Inc.?
The principal executive offices are located at 5 WALNUT GROVE DRIVE, SUITE 140, HORSHAM, Pennsylvania 19044.
What is the filing date of this Current Report (8-K)?
This Current Report (8-K) was filed on June 25, 2024.
Filing Stats: 412 words · 2 min read · ~1 pages · Grade level 11.6 · Accepted 2024-06-25 17:00:26
Key Financial Figures
- $0.001 — ange on which registered Common Stock, $0.001 par value per share SSKN NASDAQ I
Filing Documents
- ef20031660_8k.htm (8-K) — 24KB
- 0001140361-24-031327.txt ( ) — 157KB
- sskn-20240624.xsd (EX-101.SCH) — 4KB
- sskn-20240624_lab.xml (EX-101.LAB) — 21KB
- sskn-20240624_pre.xml (EX-101.PRE) — 16KB
- ef20031660_8k_htm.xml (XML) — 4KB
01
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On June 24, 2024 STRATA Skin Sciences, Inc. (the "Company") received notice from The NASDAQ Stock Market ("Nasdaq") that, STRATA has regained compliance with the Nasdaq listing requirements as required by Rule 5550(a)(2), and the Company will continue to trade on Nasdaq. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. STRATA SKIN SCIENCES, INC. Date: June 24, 2024 By: /s/ Christopher Lesovitz Christopher Lesovitz Chief Financial Officer - 2 -